Results 41 to 50 of about 2,038,094 (307)

Cardiovascular changes after administration of aerosolized salbutamol in horses: five cases [PDF]

open access: yes, 2014
Prevention and treatment of intraoperative hypoxemia in horses is difficult and both efficacy and safety of therapeutic maneuvers have to be taken into account.
AE Wagner   +24 more
core   +5 more sources

Application of hazard vulnerability analysis on risk assessment in a blood bank

open access: yesZhongguo shuxue zazhi
Objective To conduct hazard vulnerability analysis(HVA) in a blood bank, aimed to identify high-risk events and optimize emergency management measures.
ZHANG Yang   +5 more
doaj   +1 more source

Reactogenicity of Cervarix and Gardasil human papillomavirus (HPV) vaccines in a randomized single blind trial in healthy UK adolescent females

open access: yesHuman Vaccines & Immunotherapeutics, 2017
One hundred and ninety eight females aged 12–15 y were enrolled in an observer-blinded randomized trial to assess the immunogenicity and reactogenicity of the tetravalent HPV vaccine Gardasil® (group 2), in comparison to the bivalent HPV vaccine ...
Tao Haskins-Coulter   +3 more
doaj   +1 more source

Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials [PDF]

open access: yes, 2018
Background: This study assessed the immunogenicity of pegvaliase (recombinant Anabaena variabilis phenylalanine [Phe] ammonia lyase [PAL] conjugated with polyethylene glycol [PEG]) treatment in adults with phenylketonuria (PKU) and its impact on safety ...
Atkinson, John P   +14 more
core   +2 more sources

Blood clearance and tissue distribution of PEGylated and non-PEGylated gold nanorods after intravenous administration in rats\ud [PDF]

open access: yes, 2011
Aims: To develop and determine the safety of gold nanorods, whose aspect ratios can be tuned to obtain plasmon peaks between 650 and 850 nm, as contrast enhancing agents for diagnostic and therapeutic applications.
Jong, Wim H. de   +7 more
core   +4 more sources

Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The alteplase dose assessment for Pleural infection Therapy project [PDF]

open access: yes, 2017
Rationale: Intrapleural therapy with a combination of tissue plasminogen activator (tPA) 10 mg and DNase 5 mg administered twice daily has been shown in randomized and open-label studies to successfully manage over 90% of patients with pleural infection ...
Bintcliffe, Oliver   +10 more
core   +1 more source

BLOOD PRODUCT SAFETY

open access: yesJournal of Medical Laboratory and Science, 2022
Background: Blood transfusion services are attempted to utilize human blood as a basic element for humanitarian purposes. Both blood and blood products are playing a crucial role in health services. Blood transfusion is a medical procedure that contains risks due to the possible risk of Blood-transfusion related infectious disease.
openaire   +1 more source

Study on the elimination of leukocyte interference with apheresis platelet RNA assay

open access: yesZhongguo shuxue zazhi
Objective To investigate the effect of a small amount of leukocyte mixed in platelets on platelet RNA related study, and to further propose a method to remove leukocyte contamination.
LIN Fengqiu, LI Xiaofeng, LI Jianping
doaj   +1 more source

Analysis of monitoring results of novel coronavirus IgM and IgG antibody levels in apheresis platelets donors and impact on blood safety

open access: yesZhongguo shuxue zazhi, 2023
Objective To monitor the positive rates of IgM and IgG antibodies and the changes in S/CO values over time in voluntary blood donors infected with SARS-CoV-2 after recovery, in order to provide theoretical basis and data support for ensuring clinical ...
Hui ZHANG   +6 more
doaj   +1 more source

Human parvovirus B19 and blood product safety. A tale of twenty years of improvements [PDF]

open access: yes, 2015
Parvovirus B19 (B19V), long known to be the causative agent of erythema infectiosum (fifth disease), is not a newly emerging agent. The aim of this review is to analyse the role played by this virus in compromising safety in transfusion medicine and the ...
Calizzani, Gabriele   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy